Experienced in Pancreatic Islet Cell Tumor

Alexander B. Mcewan

Edmonton, AB, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Pancreatic Islet Cell Tumor
Edmonton, AB, CA 
OverviewLocationsClinical Research

Overview

Alexander Mcewan practices in Edmonton, Canada. Mr. Mcewan is rated as an Experienced expert by MediFind in the treatment of Pancreatic Islet Cell Tumor. His top areas of expertise are Hereditary Paraganglioma-Pheochromocytoma Syndrome, Neuroendocrine Tumor, Thyroid Cancer, Metastatic Insulinoma, and Thyroidectomy.

His clinical research consists of co-authoring 44 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles and participated in 1 clinical trial in the study of Pancreatic Islet Cell Tumor.

Gender
Male

Locations

Edmonton, AB, Canada
Other Locations
Edmonton, Canada
London, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open-label Phase II Study of Lutetium-177 [DOTA0, Tyr3] Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours
An Open-label Phase II Study of Lutetium-177 [DOTA0, Tyr3] Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours
Enrollment Status: Recruiting
Publish Date: August 08, 2025
Intervention Type: Drug
Study Drug: [177]Lu-DOTA-TATE
Study Phase: Phase 2
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2024
Intervention Type: Drug
A Contiguous, Sequential Phase I/II Imaging Study of 18F-fluoro-3'-L-fluorothymidine (18F-FLT) in Patients With Known or Suspected Carcinoma of the Lung, Breast, Renal Cell, Pancreas, or Brain, and With Gastrointestinal Malignancies, Neuroendocrine Tumours or Lymphoma
A Contiguous, Sequential Phase I/II Imaging Study of 18F-fluoro-3'-L-fluorothymidine (18F-FLT) in Patients With Known or Suspected Carcinoma of the Lung, Breast, Renal Cell, Pancreas, or Brain, and With Gastrointestinal Malignancies, Neuroendocrine Tumours or Lymphoma
Enrollment Status: Terminated
Publish Date: August 22, 2019
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA
A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA
Enrollment Status: Withdrawn
Publish Date: November 14, 2017
Intervention Type: Other
View 3 Less Clinical Trials

44 Total Publications

Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 02, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mcewan's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile